{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"fadd-related-immunodeficiency","columns":[{"gene":"","key":"population-cb211ca9751344c2095c","label":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","mondoId":"MONDO:0013408","onsetQualifier":null,"originColumnKey":"MONDO:0013408/OMIM:613759","originalViews":[{"key":"MONDO:0013408/OMIM:613759","label":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","scopeLabel":"OMIM:613759","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["3450aca54d21470ff02814d5b49f482b9c34afd62a20668a9e3d2c5c250a20b5","3ba8bd30e3da14a4a477d5d641f550976fd484c157b588b16bfeae5dc415125a","5824b57400b9182ad3a075db7db4aecd3368bdc818b18228d46fa045a5674781","721bbc94396a4ba88da588720d0154749834092f5932e99224f3b59f166e8766","727b4bcb1aba53b2bd8520b0552e6ac116e8d6a23b95fb5b8c343dd4ded7b907","7563c83c044ca5f4c1b80ab8fc3d9d91311b4db65e66983904fe291f5beb22fd","82b2b1c2e13eeba7434ff8b6a3c6f065a3389ffaa16fc811322e869d5267291d","97ae979e3d59b3865d33afe93f1e2e92fc3452f20df923cee6dd2b159f19266b","b65f1da3873176efa056cfb894890efbdc7eac610e4afb4ac32510fe6d806797","c25810c50326fd517b5d376c5cde04c852f0d882364bbae47bbd24601eb01d6e","e012b2216ce5d07722b8a17903d2c91a7ff3a8e4470bfae32511e0d5ba51797a","fa25cefd0d2c12535c1962a16a2635007b2e009b87c05667194d97719f125f5c"],"recordQualifiers":{},"scopeLabel":"OMIM:613759","sourceIds":["OMIM:613759"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-adf813e15a4df81a11b6","label":"FADD-related immunodeficiency","mondoId":"MONDO:0013408","onsetQualifier":null,"originColumnKey":"MONDO:0013408/ORPHA:306550","originalViews":[{"key":"MONDO:0013408/ORPHA:306550","label":"FADD-related immunodeficiency","scopeLabel":"ORPHA:306550","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["064528d1107d96bb663a7dd4491316eb4533a9aaffdf93fecfd5862330726666","0cd184cc1fc31bb97d278cba91546c4c29dd306bbe0075f013956c1d69d8f57c","15dc41271a27476bffdc39deb3beceec1034b2e5e5f50176e7bd01e0be1c0ebb","17dca475cbc5c73739ce78a187055db91d5a5bae0aa8e1bb3db07042717c8db8","54accb32b7097b0d090ac590cbba1c320b04db2a5b32ee65b006f000616ecaf2","82a6358728229c6073b75a153cd19879fefb419567a7ca2b963b9cf8d3b209f9","97e4c1238d255a71c1779c562844f4101508333ea80efe78320d01e57f3c2018","e2924a294a68476572a374e2f1fbf69d15e7f2447836a240a5f581cae188458b"],"recordQualifiers":{},"scopeLabel":"ORPHA:306550","sourceIds":["ORPHA:306550"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-cb211ca9751344c2095c","population-adf813e15a4df81a11b6"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0030057","HP:0002059","HP:0001410","HP:0031964","HP:0001298","HP:0012852","HP:0001395"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":20,"sourceGroups":{"orphanet":8,"published":12}},"features":[{"hpoId":"HP:0030057","label":"Autoimmune antibody positivity","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0001410","label":"Decreased liver function","primary":true},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":true},{"hpoId":"HP:0001298","label":"Encephalopathy","primary":true},{"hpoId":"HP:0012852","label":"Hepatic bridging fibrosis","primary":true},{"hpoId":"HP:0001395","label":"Hepatic fibrosis","primary":true},{"hpoId":"HP:0032550","label":"Howell-Jolly bodies","primary":false},{"hpoId":"HP:0033199","label":"Increased circulating interleukin 10 concentration","primary":false},{"hpoId":"HP:0011669","label":"Left superior vena cava draining directly to the left atrium","primary":false},{"hpoId":"HP:0033196","label":"Portal inflammation","primary":false},{"hpoId":"HP:0004935","label":"Pulmonary artery atresia","primary":false},{"hpoId":"HP:0002719","label":"Recurrent infections","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0001629","label":"Ventricular septal defect","primary":false}],"ledeHtml":"FADD-related immunodeficiency is a rare genetic immunological disease presenting with severe bacterial and viral infections, recurrent hepatopathy (portal inflammation, fibrosis), and recurrent, stereotypical febrile episodes, sometimes lasting several days, with encephalopathy and difficult-to-control seizures. Variable cardiac malformations were also reported. Although there were autoimmune lymphoproliferative syndrome (ALPS)-like biological features, clinical ALPS was not present. A homozygous missense mutation in the FADD gene (11q13.3) has been related to the disease and is thought to follow an autosomal recessive pattern of inheritance.","mondoId":"MONDO:0013408","node":{"canonicalSlug":"fadd-related-immunodeficiency","comparisons":[{"documentSha256":"a81b605fa40ca9801da956704d5e68393bdcc0489e88bb3fda3c4293aa31844e","key":"legacy-fadd-related-immunodeficiency","kind":"legacy","label":"FADD-related immunodeficiency","memberIds":["MONDO:0013408"],"mondoId":"MONDO:0013408","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/fadd-related-immunodeficiency.a81b605fa40ca9801da956704d5e68393bdcc0489e88bb3fda3c4293aa31844e.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"FADD-related immunodeficiency","originalSourceId":"ORPHA:306550","paragraphs":["FADD-related immunodeficiency is a rare genetic immunological disease presenting with severe bacterial and viral infections, recurrent hepatopathy (portal inflammation, fibrosis), and recurrent, stereotypical febrile episodes, sometimes lasting several days, with encephalopathy and difficult-to-control seizures. Variable cardiac malformations were also reported. Although there were autoimmune lymphoproliferative syndrome (ALPS)-like biological features, clinical ALPS was not present. A homozygous missense mutation in the FADD gene (11q13.3) has been related to the disease and is thought to follow an autosomal recessive pattern of inheritance."],"rawAttribution":"MONDO:0013408","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:00:49Z","upstream":"ORPHA:306550","url":"https://rarediseases.info.nih.gov/diseases/15004"},"ownColumnKeys":["population-cb211ca9751344c2095c","population-adf813e15a4df81a11b6"],"publication":"published","relationships":[{"kind":"parent","label":"immunodeficiency disease","mondoId":"MONDO:0021094","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"064528d1107d96bb663a7dd4491316eb4533a9aaffdf93fecfd5862330726666","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:306550","disease_name":"FADD-related immunodeficiency","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0001410","is_excluded":false,"label":"Decreased liver function","onset_id":null,"reference":"ORPHA:306550","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0cd184cc1fc31bb97d278cba91546c4c29dd306bbe0075f013956c1d69d8f57c","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:306550","disease_name":"FADD-related immunodeficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001395","is_excluded":false,"label":"Hepatic fibrosis","onset_id":null,"reference":"ORPHA:306550","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"15dc41271a27476bffdc39deb3beceec1034b2e5e5f50176e7bd01e0be1c0ebb","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:306550","disease_name":"FADD-related immunodeficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001629","is_excluded":false,"label":"Ventricular septal defect","onset_id":null,"reference":"ORPHA:306550","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"17dca475cbc5c73739ce78a187055db91d5a5bae0aa8e1bb3db07042717c8db8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:306550","disease_name":"FADD-related immunodeficiency","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:306550","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"3450aca54d21470ff02814d5b49f482b9c34afd62a20668a9e3d2c5c250a20b5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3ba8bd30e3da14a4a477d5d641f550976fd484c157b588b16bfeae5dc415125a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0004935","is_excluded":false,"label":"Pulmonary artery atresia","onset_id":"HP:0003577","reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"54accb32b7097b0d090ac590cbba1c320b04db2a5b32ee65b006f000616ecaf2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:306550","disease_name":"FADD-related immunodeficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"ORPHA:306550","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"5824b57400b9182ad3a075db7db4aecd3368bdc818b18228d46fa045a5674781","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"721bbc94396a4ba88da588720d0154749834092f5932e99224f3b59f166e8766","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0032550","is_excluded":false,"label":"Howell-Jolly bodies","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"727b4bcb1aba53b2bd8520b0552e6ac116e8d6a23b95fb5b8c343dd4ded7b907","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7563c83c044ca5f4c1b80ab8fc3d9d91311b4db65e66983904fe291f5beb22fd","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0001629","is_excluded":false,"label":"Ventricular septal defect","onset_id":"HP:0003577","reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"82a6358728229c6073b75a153cd19879fefb419567a7ca2b963b9cf8d3b209f9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:306550","disease_name":"FADD-related immunodeficiency","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"ORPHA:306550","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"82b2b1c2e13eeba7434ff8b6a3c6f065a3389ffaa16fc811322e869d5267291d","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0033199","is_excluded":false,"label":"Increased circulating interleukin 10 concentration","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"97ae979e3d59b3865d33afe93f1e2e92fc3452f20df923cee6dd2b159f19266b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"97e4c1238d255a71c1779c562844f4101508333ea80efe78320d01e57f3c2018","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:306550","disease_name":"FADD-related immunodeficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004935","is_excluded":false,"label":"Pulmonary artery atresia","onset_id":null,"reference":"ORPHA:306550","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b65f1da3873176efa056cfb894890efbdc7eac610e4afb4ac32510fe6d806797","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0012852","is_excluded":false,"label":"Hepatic bridging fibrosis","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c25810c50326fd517b5d376c5cde04c852f0d882364bbae47bbd24601eb01d6e","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002719","is_excluded":false,"label":"Recurrent infections","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e012b2216ce5d07722b8a17903d2c91a7ff3a8e4470bfae32511e0d5ba51797a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0011669","is_excluded":false,"label":"Left superior vena cava draining directly to the left atrium","onset_id":"HP:0003577","reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e2924a294a68476572a374e2f1fbf69d15e7f2447836a240a5f581cae188458b","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:306550","disease_name":"FADD-related immunodeficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030057","is_excluded":false,"label":"Autoimmune antibody positivity","onset_id":null,"reference":"ORPHA:306550","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"fa25cefd0d2c12535c1962a16a2635007b2e009b87c05667194d97719f125f5c","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:613759","disease_name":"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0033196","is_excluded":false,"label":"Portal inflammation","onset_id":null,"reference":"PMID:21109225","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/15004\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013408\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:306550</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>FADD-related immunodeficiency is a rare genetic immunological disease presenting with severe bacterial and viral infections, recurrent hepatopathy (portal inflammation, fibrosis), and recurrent, stereotypical febrile episodes, sometimes lasting several days, with encephalopathy and difficult-to-control seizures. Variable cardiac malformations were also reported. Although there were autoimmune lymphoproliferative syndrome (ALPS)-like biological features, clinical ALPS was not present. A homozygous missense mutation in the FADD gene (11q13.3) has been related to the disease and is thought to follow an autosomal recessive pattern of inheritance.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/15004\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"fadd-related-immunodeficiency","sourceDocuments":[{"name":"GARD: FADD-related immunodeficiency","reviewed":null,"source_release":"2026-10-21T17:00:49Z","url":"https://rarediseases.info.nih.gov/diseases/15004"},{"name":"MONDO: FADD-related immunodeficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013408"}],"sourceNote":"","synonyms":["FADD-related immunodeficiency","immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction"],"takeawayHtml":"","title":"FADD-related immunodeficiency"},"schemaVersion":1}
